FDA Probes Safety of New Class of Diabetic Drugs

The US Food and Drug Administration revealed that it will be conducting an investigation.

The US Food and Drug Administration revealed that it will be conducting an investigation to check whether a newly approved class of type II diabetes drugs increased the risk of pancreatitis and the development of precancerous changes in the pancreas.

The class of drugs is known as incretin mimetics and some of the drugs currently being investigated by the FDA include Merck’s Januvia and Janumet, Danish-based Novo Nordisk’s Victoza and Bristol-Myers Squibb’s Byetta and Bydureon.

Type 2 Diabetes - Risk Factors - Symptoms & Signs - Management - Prevention
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of the World.

The agency revealed that pancreas tissue samples taken from a small number of patients displayed inflammation and cellular changes often seen before cancer develops. However it was quick to clarify that the investigation did not mean it believed the drugs could lead to pancreatic cancer. “FDA has not concluded these drugs may cause or contribute to the development of pancreatic cancer. At this time, patients should continue to take their medicine as directed”, an agency statement said.

Source-Medindia

Diabetes and Exercise
Regular exercise especially in type II diabetes not only helps reduce the sugar but also reduces the demand for medication by 20% and helps you stay healthy.

Diabetic Diet - Diabetes Mellitus
The diabetic diet most often recommended is high in dietary fiber (especially soluble fiber) and nutrients, but low in fat (especially saturated fat) and moderate in calories.

Gestational Diabetes About
The condition is not caused by a lack of insulin, but by the action of hormones produced during pregnancy that blocks the action of insulin.